These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Causes of death in diabetes mellitus]. Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446 [No Abstract] [Full Text] [Related]
24. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. Knatterud GL; Klimt CR; Levin ME; Jacobson ME; Goldner MG JAMA; 1978 Jul; 240(1):37-42. PubMed ID: 351218 [TBL] [Abstract][Full Text] [Related]
25. Oral substitutes for insulin: modern appraisal of their action and indications. Isr J Med Sci; 1972 Jun; 8(6):677-710. PubMed ID: 4626310 [No Abstract] [Full Text] [Related]
27. [Heart death and oral antidiabetics; the last judgement]. Touber JL Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083 [No Abstract] [Full Text] [Related]
28. [Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test]. Vailati G; Cuttica F; Montini M; Rebba A; Pagani G Clin Ter; 1974 Jan; 68(2):149-70. PubMed ID: 4596250 [No Abstract] [Full Text] [Related]
29. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy. Gray RH Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383 [No Abstract] [Full Text] [Related]
30. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents. Prout TE Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757 [No Abstract] [Full Text] [Related]
31. Therapy of type 2 diabetes, cardiovascular death, and the UGDP. Feinglos MN; Bethel MA Am Heart J; 1999 Nov; 138(5 Pt 1):S346-52. PubMed ID: 10539796 [No Abstract] [Full Text] [Related]
33. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes]. Gervasini A Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284 [No Abstract] [Full Text] [Related]
34. [Treatment with oral hypoglycemia agents in diabetes mellitus. Controlled clinical study of 2 combinations of glibenclamide and phenformin. II]. Uccella R Clin Ter; 1978 Dec; 87(5):475-98. PubMed ID: 104819 [No Abstract] [Full Text] [Related]
35. Cardiovascular disease and intensive glucose lowering in type 2 diabetes. Younis N; Soran H; Hassanein M QJM; 2009 Apr; 102(4):293-6. PubMed ID: 19147659 [No Abstract] [Full Text] [Related]
36. [Progress in the therapy of diabetes]. Raptis S; Rothenbuchner G; Pfeiffer EF Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791 [No Abstract] [Full Text] [Related]
37. [Therapy of diabetes with oral hypoglycemic agents. Controlled clinical study of 2 glibenclamide-phenformin combinations. I]. Uccella R Clin Ter; 1978 Nov; 87(4):375-83. PubMed ID: 109242 [No Abstract] [Full Text] [Related]
38. [Diabetes mellitus. Present concepts and therapeutic implications]. de L'Hortet GC; Bercovici JP Presse Med (1893); 1968 Dec; 76(50):2389-92. PubMed ID: 5734286 [No Abstract] [Full Text] [Related]
39. Seminars on diabetes. II. Principles of management. Can Med Assoc J; 1971 Nov; 105(9):972-3 passim. PubMed ID: 5150198 [No Abstract] [Full Text] [Related]
40. [Incidence of coronary cardiopathy in 416 diabetic patients treated with insulin or oral hypoglycemic agents]. Comi D; Santagostino A; Ragaini S; Baroni GC; Porro T; Pagani G Boll Soc Ital Cardiol; 1975; 20(1):73-80. PubMed ID: 1231897 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]